Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Diczfalusy

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Journal of AOAC International|May 29, 2004
Analysis of cholesterol oxidation products in biological samplesUlf Diczfalusy
Biochimie|June 27, 2012
On the formation and possible biological role of 25-hydroxycholesterolUlf Diczfalusy
Journal of Lipid Research|June 10, 2011
Still another activity by the highly promiscuous enzyme CYP3A4: 25-hydroxylation of cholesterolUlf Diczfalusy, Ingemar Björkhem
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2002
Oxysterols: friends, foes, or just fellow passengers?Ingemar Björkhem, Ulf Diczfalusy
Arteriosclerosis, Thrombosis, and Vascular Biology|December 4, 2004
24(S),25-epoxycholesterol--a potential friendIngemar Bjorkhem, Ulf Diczfalusy
Methods in Enzymology|November 25, 2003
Quantitation of receptor ligands by mass spectrometryErik G Lund, Ulf Diczfalusy
Microcirculation (New York, N.Y. : 1994)|August 19, 2011
Microvascular reactivity in response to smoking and oral antioxidants in humansPeter Henriksson, Ulf Diczfalusy, Anna Freyschuss
Current Opinion in Lipidology|June 5, 2002
Oxysterols in human circulation: which role do they have?Ingemar Björkhem, Steve Meaney, Ulf Diczfalusy
Biochimica Et Biophysica Acta|February 15, 2005
Novel pathways of bile acid metabolism involving CYP3A4Karl Bodin, Ulla Lindbom, Ulf Diczfalusy
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2004
Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapyPeter Stenvinkel, Ulf Diczfalusy, Bengt Lindholm, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Journal of AOAC International|May 29, 2004
Analysis of cholesterol oxidation products in biological samplesUlf Diczfalusy
Biochimie|June 27, 2012
On the formation and possible biological role of 25-hydroxycholesterolUlf Diczfalusy
Journal of Lipid Research|June 10, 2011
Still another activity by the highly promiscuous enzyme CYP3A4: 25-hydroxylation of cholesterolUlf Diczfalusy, Ingemar Björkhem
Arteriosclerosis, Thrombosis, and Vascular Biology|May 15, 2002
Oxysterols: friends, foes, or just fellow passengers?Ingemar Björkhem, Ulf Diczfalusy
Arteriosclerosis, Thrombosis, and Vascular Biology|December 4, 2004
24(S),25-epoxycholesterol--a potential friendIngemar Bjorkhem, Ulf Diczfalusy
Methods in Enzymology|November 25, 2003
Quantitation of receptor ligands by mass spectrometryErik G Lund, Ulf Diczfalusy
Microcirculation (New York, N.Y. : 1994)|August 19, 2011
Microvascular reactivity in response to smoking and oral antioxidants in humansPeter Henriksson, Ulf Diczfalusy, Anna Freyschuss
Current Opinion in Lipidology|June 5, 2002
Oxysterols in human circulation: which role do they have?Ingemar Björkhem, Steve Meaney, Ulf Diczfalusy
Biochimica Et Biophysica Acta|February 15, 2005
Novel pathways of bile acid metabolism involving CYP3A4Karl Bodin, Ulla Lindbom, Ulf Diczfalusy
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 20, 2004
Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapyPeter Stenvinkel, Ulf Diczfalusy, Bengt Lindholm, et al.
Pageof 8